Results 131 to 140 of about 487,550 (165)
Some of the next articles are maybe not open access.
2023
"Lunario" is one of Guidi's last books. This is undoubtedly the artist's least characteristic work – an unusual project for a photographer of streets and sites of memory, of the outskirts and of domestic spaces. Here Guidi - a visual phenomenologist of the surroundings, the variations in the appearances of which he explores in precise intervals of time
openaire +2 more sources
"Lunario" is one of Guidi's last books. This is undoubtedly the artist's least characteristic work – an unusual project for a photographer of streets and sites of memory, of the outskirts and of domestic spaces. Here Guidi - a visual phenomenologist of the surroundings, the variations in the appearances of which he explores in precise intervals of time
openaire +2 more sources
Genotype Calling for the Illumina Platform
2011Genome-wide association studies have been made possible because of advancements in the design of genotyping technologies to assay a million or more single nucleotide polymorphisms (SNPs) simultaneously. This has resulted in the introduction of automated and unsupervised statistical approaches for translating the probe hybridization intensities into the
openaire +2 more sources
A Guide to Illumina BeadChip Data Analysis
2017The Illumina Infinium BeadChips are a powerful array-based platform for genome-wide DNA methylation profiling at approximately 485,000 (450K) and 850,000 (EPIC) CpG sites across the genome. The platform is used in many large-scale population-based epigenetic studies of complex diseases, environmental exposures, or other experimental conditions.
Michael C, Wu, Pei-Fen, Kuan
openaire +2 more sources
Chemical & Engineering News Archive, 2012
Roche has made a hostile move to acquire Illumina for $5.7 billion in cash. The Swiss drugmaker says it made the bid after Illumina, a provider of gene-sequencing technology, refused to participate in “substantive discussions” about a friendly acquisition.
openaire +1 more source
Roche has made a hostile move to acquire Illumina for $5.7 billion in cash. The Swiss drugmaker says it made the bid after Illumina, a provider of gene-sequencing technology, refused to participate in “substantive discussions” about a friendly acquisition.
openaire +1 more source
Illumina universal bead arrays.
Methods in enzymology, 2006This chapter describes an accurate, scalable, and flexible microarray technology. It includes a miniaturized array platform where each individual feature is quality controlled and a versatile assay that can be adapted for various genetic analyses, such as single nucleotide polymorphism genotyping, DNA methylation detection, and gene expression ...
Jian-Bing, Fan +9 more
openaire +1 more source
A 16S rRNA gene sequencing and analysis protocol for the Illumina MiniSeq platform
MicrobiologyOpen, 2018Nicola Conci +2 more
exaly